Equities

JTEC Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
3446:TYO

JTEC Corp

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,061.00
  • Today's Change-123.00 / -5.63%
  • Shares traded431.70k
  • 1 Year change+63.44%
  • Beta1.3737
Data delayed at least 15 minutes, as of Feb 20 2026 04:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

JTEC Corp mainly manufactures and sells medical-related systems. The Company operates through two business segments. The main products of the Optical segment are X-ray nano-collecting mirrors for synchrotron radiation and X-ray free electron laser facilities. This segment is engaged in the manufacture and sale of special mirrors focusing on X-ray nano-collecting mirrors used for advanced analyzers for a wide range of research including basic research and industrial applications. The main products of the Life Science and Equipment Development segment are various automatic cell culture devices and other automation devices. This segment develops, sells various automatic cell culture devices. In addition to medical and biotechnology fields, it develops, manufactures and sells outsourced products and proprietary products to research institutes and companies in various fields.

  • Revenue in JPY (TTM)2.01bn
  • Net income in JPY90.61m
  • Incorporated1993
  • Employees76.00
  • Location
    JTEC Corp2-5-38, Saito-YamabukiIBARAKI-SHI 567-0086JapanJPN
  • Phone+81 726432292
  • Fax+81 726432391
  • Websitehttps://www.j-tec.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Data Horizon Co Ltd5.18bn-2.30bn6.19bn367.00--20.51--1.20-181.31-181.31407.7923.740.746621.802.4414,102,500.00-33.20---54.27--36.77---44.47--1.29-3.050.9424--------------
Precision System Science Co Ltd5.03bn-35.13m6.92bn151.00--1.7937.411.38-1.28-1.28184.10140.030.89592.265.9233,309,860.00-0.6257-4.14-0.8672-5.5530.2630.20-0.6984-6.051.521.910.1787--17.91-1.5277.43---25.44--
Aso International Inc3.95bn473.61m7.04bn310.0015.122.3913.651.7847.4947.49396.47300.461.1916.337.9512,754,750.0014.20--16.71--44.89--11.98--4.7031.510.00--7.10--13.50------
Yamashita Health Care Holdings Inc63.77bn412.00m9.00bn613.0021.260.985714.060.1411165.78165.7825,574.613,576.032.4314.255.39104,027,700.001.562.244.396.5313.5013.100.6430.89750.945--0.0032.954.76-0.05346.216.0343.356.79
Koken Ltd11.86bn885.29m10.01bn321.0010.910.69937.690.8446179.77179.772,408.462,805.840.54762.482.30--4.093.905.214.9545.4045.897.477.411.6823.740.295719.1510.173.1522.611.11-11.116.96
Kainos Laboratories Inc5.46bn597.66m10.39bn157.0016.071.3514.871.90141.77141.771,294.101,688.390.61923.033.0734,748,430.006.787.128.129.3248.0951.5710.9611.493.45--0.071721.114.932.850.47879.976.9016.36
JMS Co Ltd66.09bn-224.00m10.98bn5.47k--0.26074.580.1662-9.15-9.152,695.911,703.210.76512.443.5412,084,290.00-0.36580.7427-0.53821.1022.7723.52-0.47810.88361.076.050.393671.626.833.56347.22-46.21-1.640.00
Create Medic Co Ltd13.62bn713.73m11.14bn1.00k14.140.5928.680.818381.5281.521,540.661,947.780.67761.814.29--3.553.014.073.5244.0244.005.244.514.8135.350.043959.804.514.69-15.121.591.663.99
JTEC Corp2.01bn90.61m12.11bn76.00133.214.5647.906.0315.3915.39340.67449.750.58771.5811.3526,411,460.002.651.763.021.9962.1059.574.513.782.4875.980.1480.00-4.2213.39-69.7629.84-17.34--
DVx Inc55.33bn308.75m13.18bn334.0041.511.4712.200.238329.4629.465,278.63831.732.2417.684.12165,663,400.001.252.643.286.459.6011.080.5581.281.23--0.002563.099.752.42137.18-12.33-2.4315.81
OLBA Healthcare Holdings Inc124.52bn1.23bn13.42bn1.39k10.321.056.960.1078208.00208.0021,012.962,050.242.6215.184.4989,389,400.002.603.438.3111.3911.2711.490.98981.220.966350.240.231830.513.492.61-4.6834.3828.7114.87
Japan Medical Dynamic Marketing Inc24.58bn-1.05bn13.50bn538.00--0.53525.010.5493-40.02-40.02933.26953.320.72020.63684.3445,695,190.00-3.134.27-3.804.9459.9365.20-4.355.781.2812.480.180228.508.356.79-136.31---1.378.45
Daiken Medical Co Ltd10.17bn981.12m15.25bn180.0014.031.7912.421.5034.1534.15353.89267.890.90354.563.6456,482,360.008.727.8611.8311.2538.7941.239.659.511.89183.100.193969.412.073.1511.035.01-0.18892.83
Seed Co Ltd33.57bn1.17bn16.31bn985.0013.910.87813.670.48638.7638.761,109.07613.830.642.357.4334,078,080.002.222.313.583.9445.1242.203.473.300.59286.620.575736.012.580.8892-44.3833.9912.644.56
Hoshi Iryo-Sanki Co Ltd15.45bn1.45bn17.44bn500.0011.000.825410.581.13463.58463.584,949.106,178.920.626224.075.8130,904,100.005.886.007.197.6149.7248.989.399.193.09--0.0015.312.196.784.2114.77-18.276.96
Data as of Feb 20 2026. Currency figures normalised to JTEC Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
Amova Asset Management Co., Ltd.as of 31 May 2024300.000.01%
State Street Global Advisors (Japan) Co. Ltd.as of 05 Mar 2024100.000.00%
Resona Asset Management Co., Ltd.as of 10 Dec 2024100.000.00%
Nomura Asset Management Co., Ltd.as of 29 Sep 2025100.000.00%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 10 Sep 20250.000.00%
Chibagin Asset Management Co. Ltd.as of 30 May 20240.000.00%
More ▼
Data from 22 Jul 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.